Taiho And Helsinn Sign License For Nausea Drug
This article was originally published in PharmAsia News
Executive Summary
Ostuka Holdings Co. Ltd subsidiary Taiho Pharmaceutical and Helsinn Healthcare SA of Switzerland signed a licensing agreement for Japan rights of a nausea compound